Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Sky One Receives Two New SFDA Approvals

publication date: Dec 9, 2008

China Sky One Medical (中国天字一号医药公司) said that its newly acquired subsidiary, Peng Lai Jin Chuang Pharmaceutical Company, received approval from the SFDA to being producing two new drugs. Tinea Liniment is a TCM that treats various skin fungal infections, and Skincare Cream is a traditional Chinese medicine intended for the treatment of skin diseases such as acne, bottle nose, chromophytosis and vitiligo. More details...

Stock Symbol: (NSDQ: CSKI)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital